Capecitabine-Associated Loss of Fingerprints: A Case Report of a 62-Year-Old Man With Colorectal Cancer Suffering From Capecitabine-Induced Adermatoglyphia

Background: Capecitabine is a prodrug of 5-fluorouracil (5-FU) and is converted to 5-FU in tumor tissue. Its primary mechanism of action is the suppression of DNA synthesis via inhibition of thymidylate synthetase. It is mostly used for neoadjuvant chemoradiation, adjuvant chemotherapy for colorecta...

Descripción completa

Detalles Bibliográficos
Autores principales: Dawood, Tasneem, Zahir, Muhammad Nauman, Afzal, Muhammad, Rashid, Yasmin Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265279/
https://www.ncbi.nlm.nih.gov/pubmed/34268045
http://dx.doi.org/10.7759/cureus.15519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265279/
https://www.ncbi.nlm.nih.gov/pubmed/34268045
http://dx.doi.org/10.7759/cureus.15519

Ejemplares similares